Treatment of oncologic emergencies

American Family Physician

Volumn 74, Issue 11, 2006, Pages 1873-1880

  Higdon, Mark L ^a,c   Higdon, Jennifer A ^b  

^a MARTIN ARMY COMMUNITY HOSPITAL   (United States)

^b Medical Center Family Medicine Residency   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIEMETIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CORTASTAT; DEMECLOCYCLINE; DEXAMETHASONE; DIURETIC AGENT; FIBRINOLYTIC AGENT; FUROSEMIDE; GALLIUM NITRATE; GLUCOCORTICOID; MITHRAMYCIN; NARCOTIC AGENT; PAMIDRONIC ACID; SALCATONIN; URATE OXIDASE; VANCOMYCIN; VASOPRESSIN; ZOLEDRONIC ACID;

ANTICOAGULANT THERAPY; BACTERIAL INFECTION; CANCER; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DEHYDRATION; DIARRHEA; DISEASE ASSOCIATION; EMERGENCY CARE; EXTRAVASATION; FEBRILE NEUTROPENIA; HEMATOLOGIC MALIGNANCY; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERVISCOSITY SYNDROME; HYPONATREMIA; LUNG CARCINOMA; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PENICILLIN RESISTANCE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PHLEBOGRAPHY; PLASMAPHERESIS; RADIOGRAPHY; REHYDRATION; REVIEW; SPINAL CORD COMPRESSION; STENT; SUPERIOR CAVA VEIN SYNDROME; TUMOR LYSIS SYNDROME; UNSPECIFIED SIDE EFFECT; VOMITING; WALDENSTROEM MACROGLOBULINEMIA;

ANTINEOPLASTIC AGENTS; BLOOD VISCOSITY; HUMANS; HYPERCALCEMIA; IMMUNOGLOBULINS; INAPPROPRIATE ADH SYNDROME; NEOPLASMS; NEUTROPENIA; SPINAL CORD COMPRESSION; TUMOR LYSIS SYNDROME;

EID: 33845356186     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Brigden ML. Hematologic and oncologic emergencies. Doing the most good in the least time. Postgrad Med 2001;109:143-6, 151-4, 157-8.
2. Newton HB. Neurologic complications of systemic cancer [Published correction appears in Am Fam Physician 1999;59:2435]. Am Fam Physician 1999;59:878-86.
3. Kattlove H, Winn RJ. Ongoing care of patients after primary treatment for their cancer [Published correction appears in CA Cancer J Clin 2003;53:315]. CA Cancer J Clin 2003;54:172-96.
4. Rhodes V, Manzullo E. Oncologic emergencies. In: Pazdur R. Medical Oncology: A Comprehensive Review. 2nd ed. Huntington, N.Y.: PRR, 1997.
5. Krimsky WS, Behrens RJ, Kerkvliet GJ. Oncologic emergencies for the internist. Cleve Clin J Med 2002;69:209-10, 213-4, 216-7.
6. Gucalp R, Dutcher J. Oncologic emergencies. Best practice report. Accessed March 9, 2006, at http://merck.micromedex.com/index.asp?page= bpm_brief&article_id=CPM01ON243.
7. Roodman GD. Biology of osteoclast activation in cancer. J Clin Oncol 2001;19:3562-71.
8. Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC, et al. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002;20:3719-36.
9. Gertz MA, Fonseca R, Rajkumar SV. Waldenström's macroglobulinemia. Oncologist 2000;5:63-7.
10. Beeson MS. Superior vena cava syndrome. Accessed March 9, 2006, at: http://www.emedicine.com/EMERG/topic561.htm.
11. Drews RE. Superior vena cava syndrome. Accessed March 9, 2006, at: http://patients.uptodate.com/topic.asp?file=genl_onc/8555.
12. Schiff D. Clinical features and diagnosis of epidural spinal cord compression, including cauda equina syndrome. Accessed March 9, 2006, at: http://patients.uptodate.com/topic.asp?file=genl_onc/5033.
13. Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001;97:2998-3003.
14. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005;352:373-9.
15. Inzucchi SE. Understanding hypercalcemia. Its metabolic basis, signs, and symptoms. Postgrad Med 2004;115:69-70, 73-6.
16. Agus ZS. Hypercalcemia of malignancy. Accessed March 9, 2006, at: http://patients.uptodate.com/topic.asp?file=minmetab/7246 (subscription required).
17. Goltzman D. Approach to hypercalcemia. In: Arnold A, ed. Diseases of Bone and Calcium Metabolism. Accessed March 9, 2006, at: http://www.endotext.com/ parathyroid/index.htm.
18. Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 2001;19:558-67.
19. Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer 2003;98:1735-44.
20. Pavlakis N, Schmidt R, Stockler M. Bisphosphonates for breast cancer. Cochrane Database Syst Rev 2005;(3):CD003474.
21. Goh KP. Management of hyponatremia. Am Fam Physician 2004;69:2387-94.
22. Viscoli C. The evolution of the empirical management of fever and neutropenia in cancer patients. J Antimicrob Chemother 1998;41(suppl D):S65-80.
23. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51.
24. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992;10:316-22.
25. Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Colomer R, Perea S, et al. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial. Cancer 1999;85:213-9.
26. Niho S, Ohe Y, Goto K, Ohmatsu H, Matsumoto T, Kubota K, et al. Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer. Jpn J Clin Oncol 2004;34:69-73.
27. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000;18:3038-51.
28. Kupas DF. Hyperviscosity syndrome. Accessed March 9, 2006, at: http://www.emedicine.com/emerg/topic756.htm.
29. Naughton M. Medical management of medical disease. In: Green GB, Harris IS, Lin GA, Moylan KC, eds. The Washington Manual of Medical Therapeutics. 31st ed. Philadelphia, Pa.: Lippincott Williams & Wilkins, 2004.
30. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev 2001;(4):CD001316.
31. Kvale PA, Simoff M, Prakash UB. American College of Chest Physicians. Lung cancer. Palliative care. Chest 2003;123(suppl):S284-311.
32. Quint DJ. Indications for emergent MRI of the central nervous system. JAMA 2000;283:853-5.
33. Bilsky MH, Lis E, Raizer J, Lee H, Boland P. The diagnosis and treatment of metastatic spinal tumor. Oncologist 1999;4:459-69.
34. Yamada KA, Awadalla S. Acute spinal cord dysfunction. In: Green GB, Harris IS, Lin GA, Moylan KC, eds. The Washington Manual of Medical Therapeutics. 31st ed. Philadelphia, Pa.: Lippincott Williams & Wilkins, 2004.
35. Sorensen S, Helweg-Larsen S, Mouridsen H, Hansen HH. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer 1994;30A:22-7.
36. Heimdal K, Hirschberg H, Slettebo H, Watne K, Nome O. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol 1992;12:141-4.
37. Martinoni A, Cipolla CM, Cardinale D, Civelli M, Lamantia G, Colleoni M, et al. Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa. Chest 2004;126:1412-6.
38. Thomas S, Rowe HN, Keats J, Morgan RJ. The management of extravasation injury in neonates. Accessed March 9, 2006, at: http://www.worldwidewounds.com/ 1997/october/Neonates/NeonatePaper.html.